• 1
    Maron BJ, Towbin JA, Thiene G, et al. Contemporary definitions and classification of the cardiomyopathies: An American Heart Association Scientific Statement from the Council on Clinical Cardiology, Heart Failure and Transplantation Committee; Quality of Care and Outcomes Research and Functional Genomics and Translational Biology Interdisciplinary Working Groups; and Council on Epidemiology and Prevention. Circulation 2006;113:18071816.
  • 2
    Maron BJ, Gardin JM, Flack JM, et al. Prevalence of hypertrophic cardiomyopathy in a general population of young adults. Echocardiographic analysis of 4111 subjects in the CARDIA Study. Coronary Artery Risk Development in (Young) Adults. Circulation 1995;92:785789.
  • 3
    Ferasin L, Sturgess CP, Cannon MJ, et al. Feline idiopathic cardiomyopathy: A retrospective study of 106 cats (1994–2001). J Feline Med Surg 2003;5:151159.
  • 4
    Liu SK, Maron BJ, Tilley LP. Feline hypertrophic cardiomyopathy: Gross anatomic and quantitative histologic features. Am J Pathol 1981;102:388395.
  • 5
    Atkins CE, Gallo AM, Kurzman ID, et al. Risk factors, clinical signs, and survival in cats with a clinical diagnosis of idiopathic hypertrophic cardiomyopathy: 74 cases (1985–1989). J Am Vet Med Assoc 1992;201:613618.
  • 6
    Kittleson MD, Pion PD, Mekhamer Y. Hypertrophic cardiomyopathy in a group of interrelated Maine Coon cats. J Vet Intern Med 1993;7:117.
  • 7
    Fox PR, Liu SK, Maron BJ. Echocardiographic assessment of spontaneously occurring feline hypertrophic cardiomyopathy. An animal model of human disease. Circulation 1995;92:26452651.
  • 8
    Rush JE, Freeman LM, Fenollosa NK, et al. Population and survival characteristics of cats with hypertrophic cardiomyopathy: 260 cases (1990–1999). J Am Vet Med Assoc 2002;220:202207.
  • 9
    Peterson EN, Moise NS, Brown CA, et al. Heterogeneity of hypertrophy in feline hypertrophic heart disease. J Vet Intern Med 1993;7:183189.
  • 10
    Payne J, Luis Fuentes V, Boswood A, et al. Population characteristics and survival in 127 referred cats with hypertrophic cardiomyopathy (1997 to 2005). J Small Anim Pract 2010;51:540547.
  • 11
    Trehiou-Sechi E, Tissier R, Gouni V, et al. Comparative echocardiographic and clinical features of hypertrophic cardiomyopathy in 5 breeds of cats: A retrospective analysis of 344 cases (2001–2011). J Vet Intern Med 2012;26:532541.
  • 12
    Schober KE, Zientek J, Li X, et al. Effect of treatment with atenolol on 5-year survival in cats with preclinical (asymptomatic) hypertrophic cardiomyopathy. J Vet Cardiol 2013;15:93104.
  • 13
    Maron MS, Olivotto I, Betocchi S, et al. Effect of left ventricular outflow tract obstruction on clinical outcome in hypertrophic cardiomyopathy. N Engl J Med 2003;348:295303.
  • 14
    Autore C, Bernabo P, Barilla CS, et al. The prognostic importance of left ventricular outflow obstruction in hypertrophic cardiomyopathy varies in relation to the severity of symptoms. J Am Coll Cardiol 2005;45:10761080.
  • 15
    Elliott PM, Gimeno JR, Tome MT, et al. Left ventricular outflow tract obstruction and sudden death risk in patients with hypertrophic cardiomyopathy. Eur Heart J 2006;27:19331941.
  • 16
    Blume GG, McLeod CJ, Barnes ME, et al. Left atrial function: Physiology, assessment, and clinical implications. Eur J Echocardiogr 2011;12:421430.
  • 17
    Maron BJ, McKenna WJ, Danielson GK, et al. American College of Cardiology/European Society of Cardiology clinical expert consensus document on hypertrophic cardiomyopathy. A report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents and the European Society of Cardiology Committee for Practice Guidelines. J Am Coll Cardiol 2003;42:16871713.
  • 18
    Biagini E, Coccolo F, Ferlito M, et al. Dilated-hypokinetic evolution of hypertrophic cardiomyopathy: Prevalence, incidence, risk factors, and prognostic implications in pediatric and adult patients. J Am Coll Cardiol 2005;46:15431550.
  • 19
    Harris KM, Spirito P, Maron MS, et al. Prevalence, clinical profile, and significance of left ventricular remodeling in the end-stage phase of hypertrophic cardiomyopathy. Circulation 2006;114:216225.
  • 20
    Xie GY, Berk MR, Smith MD, et al. Prognostic value of Doppler transmitral flow patterns in patients with congestive heart failure. J Am Coll Cardiol 1994;24:132139.
  • 21
    Dini FL, Dell'Anna R, Micheli A, et al. Impact of blunted pulmonary venous flow on the outcome of patients with left ventricular systolic dysfunction secondary to either ischemic or idiopathic dilated cardiomyopathy. Am J Cardiol 2000;85:14551460.
  • 22
    Hansen A, Haass M, Zugck C, et al. Prognostic value of Doppler echocardiographic mitral inflow patterns: Implications for risk stratification in patients with chronic congestive heart failure. J Am Coll Cardiol 2001;37:10491055.
  • 23
    Hillis GS, Moller JE, Pellikka PA, et al. Noninvasive estimation of left ventricular filling pressure by E/e' is a powerful predictor of survival after acute myocardial infarction. J Am Coll Cardiol 2004;43:360367.
  • 24
    Troughton RW, Prior DL, Frampton CM, et al. Usefulness of tissue doppler and color M-mode indexes of left ventricular diastolic function in predicting outcomes in systolic left ventricular heart failure (from the ADEPT study). Am J Cardiol 2005;96:257262.
  • 25
    Wang M, Yip G, Yu CM, et al. Independent and incremental prognostic value of early mitral annulus velocity in patients with impaired left ventricular systolic function. J Am Coll Cardiol 2005;45:272277.
  • 26
    Okura H, Takada Y, Kubo T, et al. Tissue Doppler-derived index of left ventricular filling pressure, E/E', predicts survival of patients with non-valvular atrial fibrillation. Heart 2006;92:12481252.
  • 27
    Kubo T, Gimeno JR, Bahl A, et al. Prevalence, clinical significance, and genetic basis of hypertrophic cardiomyopathy with restrictive phenotype. J Am Coll Cardiol 2007;49:24192426.
  • 28
    Biagini E, Spirito P, Rocchi G, et al. Prognostic implications of the Doppler restrictive filling pattern in hypertrophic cardiomyopathy. Am J Cardiol 2009;104:17271731.
  • 29
    Wagner T, Fuentes VL, Payne JR, et al. Comparison of auscultatory and echocardiographic findings in healthy adult cats. J Vet Cardiol 2010;12:171182.
  • 30
    Schober KE, Maerz I, Ludewig E, et al. Diagnostic accuracy of electrocardiography and thoracic radiography in the assessment of left atrial size in cats: Comparison with transthoracic 2-dimensional echocardiography. J Vet Intern Med 2007;21:709718.
  • 31
    Schober KE, Maerz I. Doppler echocardiographic assessment of left atrial appendage flow velocities in normal cats. J Vet Cardiol 2005;7:1525.
  • 32
    Abhayaratna WP, Seward JB, Appleton CP, et al. Left atrial size: Physiologic determinants and clinical applications. J Am Coll Cardiol 2006;47:23572363.
  • 33
    Bang CN, Dalsgaard M, Greve AM, et al. Left atrial size and function as predictors of new-onset of atrial fibrillation in patients with asymptomatic aortic stenosis: The simvastatin and ezetimibe in aortic stenosis study. Int J Cardiol 2013; doi: 10.1016/j.ijcard.2013.01.060. [Epub ahead of print]
  • 34
    Abbott JA, MacLean HN. Two-dimensional echocardiographic assessment of the feline left atrium. J Vet Intern Med 2006;20:111119.
  • 35
    Schober KE, Fuentes VL, Bonagura JD. Comparison between invasive hemodynamic measurements and noninvasive assessment of left ventricular diastolic function by use of Doppler echocardiography in healthy anesthetized cats. Am J Vet Res 2003;64:93103.
  • 36
    Schober KE, Maerz I. Assessment of left atrial appendage flow velocity and its relation to spontaneous echocardiographic contrast in 89 cats with myocardial disease. J Vet Intern Med 2006;20:120130.
  • 37
    Côté E, Harpster NK, Laste NJ, et al. Atrial fibrillation in cats: 50 cases (1979–2002). J Am Vet Med Assoc 2004;225:256260.
  • 38
    Dohoo I, Martin W, Stryhn H. Modelling survival data. In: Dohoo I, Martin W, Stryhn H, eds. Veterinary Epidemiological Research, 2nd ed, Charlottetown, PE: VER Inc; 2009:467528.
  • 39
    Johns SM, Nelson OL, Gay JM. Left atrial function in cats with left-sided cardiac disease and pleural effusion or pulmonary edema. J Vet Intern Med 2012;26:11341139.
  • 40
    Baty CJ, Malarkey DE, Atkins CE, et al. Natural history of hypertrophic cardiomyopathy and aortic thromboembolism in a family of domestic shorthair cats. J Vet Intern Med 2001;15:595599.
  • 41
    Cesta MF, Baty CJ, Keene BW, et al. Pathology of end-stage remodeling in a family of cats with hypertrophic cardiomyopathy. Vet Pathol 2005;42:458467.
  • 42
    Spirito P, Bellone P, Harris KM, et al. Magnitude of left ventricular hypertrophy and risk of sudden death in hypertrophic cardiomyopathy. N Engl J Med 2000;342:17781785.
  • 43
    Olivotto I, Cecchi F, Casey SA, et al. Impact of atrial fibrillation on the clinical course of hypertrophic cardiomyopathy. Circulation 2001;104:25172524.
  • 44
    Maron BJ, Olivotto I, Bellone P, et al. Clinical profile of stroke in 900 patients with hypertrophic cardiomyopathy. J Am Coll Cardiol 2002;39:301307.
  • 45
    Olivotto I, Maron MS, Adabag AS, et al. Gender-related differences in the clinical presentation and outcome of hypertrophic cardiomyopathy. J Am Coll Cardiol 2005;46:480487.
  • 46
    Kittleson MD, Meurs KM, Munro MJ, et al. Familial hypertrophic cardiomyopathy in maine coon cats: An animal model of human disease. Circulation 1999;99:31723180.
  • 47
    Maron BJ. Hypertrophic cardiomyopathy: A systematic review. JAMA 2002;287:13081320.
  • 48
    Nagueh SF, Lakkis NM, Middleton KJ, et al. Doppler estimation of left ventricular filling pressures in patients with hypertrophic cardiomyopathy. Circulation 1999;99:254261.